Clinical trial

Myocardial Dysfunction in Type 2 Diabetes Mellitus (T2DM)

NCT01588470

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2006-06-01

PhasePHASE4

Study timeline

Study start (unknown)2006-06-01Date precision: month

Registry last updated2017-12-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 2 Diabetesunresolved

Coronary Heart Diseaseunresolved

Interventions

pioglitazoneDRUG · verified · RxNorm: pioglitazone

Sponsors & collaborators

The University of Texas Health Science Center at San Antoniolead sponsor

Takeda Pharmaceuticals North America, Inc.collaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01588470 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.